Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02740920 |
| Title | Assessment of Response to Pembrolizumab in Metastatic Melanoma: Computed Tomography (CT) Texture Analysis as a Predictive Biomarker |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Canadian Cancer Trials Group |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Kingston Health Sciences Centre | Kingston | Ontario | K7L 2V7 | Canada | Details | |
| London Regional Cancer Program | London | Ontario | N6A 5W9 | Canada | Details | |
| Ottawa Hospital Research Institute | Ottawa | Ontario | K1H 8L6 | Canada | Details | |
| Odette Cancer Centre | Toronto | Ontario | M4N 3M5 | Canada | Details | |
| Allan Blair Cancer Centre | Regina | Saskatchewan | S4T 7T1 | Canada | Details |